Although the precise mechanism by which EA decreases serum levels of these pro-inflammatory cytokines is unclear, it is likely that EA acts through direct inhibition of the NF-κB pathway, as shown in this study and reported in the renal disease model [54]. This evidence concerns the gene NFKB1 and kidney disorder.